Diabetologia (2023), doi: [] NICE, NICE | the National Institute for Health and Care Excellence
GLP-1s have become a popular topic because of their important role in appetite regulation, blood sugar balance, and overall metabolic health
It is our consistent pursuit to create value for clients
Once the gut is leaky, gluten can get into your bloodstream and confuse your immune system
RiskBenefit Perspective Despite theoretical concerns, the clinical reality is clear: GLP-1 therapies produce substantial weight loss Improve glycemic control and cardiometabolic outcomes Reduce cardiovascular risk in multiple studies When evaluating carcinogenicity risk, current evidence suggests: Strong rodent signals exist but may not translate to humans Long-term human data has not confirmed increased thyroid cancer risk Regulatory warnings remain precautionary rather than confirmatory Conclusion The GLP-1 receptor agonist classfrom Liraglutide to next-generation oral agents like Orforglipronrepresents one of the most transformative areas in metabolic medicine
Generic versions of semaglutide, the active ingredient in Ozempic and its sister drug Wegovy, have been legal in Canada as of Jan
